|
| (R)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide Basic information |
Product Name: | (R)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide | Synonyms: | (R)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide;Larotrectinib impurity;Larotrectinib Impurity 8;(R)-N-(2-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrrolo[1,2-a]pyrimidin-8-yl)-3-hydroxypyrrolidine-1-carboxamide;Larotrectinib Impurity 2;Larotrectinib Impurity 7;(R)-Larotrectinib;1-Pyrrolidinecarboxamide, N-[5-[(2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-, (3R)- | CAS: | 1223404-68-9 | MF: | C21H22F2N6O2 | MW: | 428.44 | EINECS: | | Product Categories: | | Mol File: | 1223404-68-9.mol | |
| (R)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide Chemical Properties |
density | 1.55±0.1 g/cm3(Predicted) | pka | 8.41±0.40(Predicted) |
| (R)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide Usage And Synthesis |
| (R)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide Preparation Products And Raw materials |
|